94 results
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
10 Jun 24
Other Events
6:05am
Frontier Program at The Children’s Hospital of Philadelphia (CHOP) Professor in the Division of Human Genetics, Department of Pediatrics at University
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
20 May 24
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia
4:08pm
at The Children’s Hospital of Philadelphia (CHOP) Professor in the Division of Human Genetics, Department of Pediatrics at University of Pennsylvania
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
9 May 24
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
7:02am
, Department of Pediatrics at University of Pennsylvania Perelman School of Medicine Marni J. Falk, MD Medical Director and Division Chief
PRE 14A
4vd f2g8mv
12 Apr 24
Preliminary proxy
6:06am
8-K
EX-99.2
n3zqpcpego5ij
11 Mar 24
Other Events
4:09pm
8-K
EX-1.1
htfe9bhbia84j5jsisd0
16 Feb 24
Entry into a Material Definitive Agreement
4:06pm
424B5
zro nw2m2
14 Feb 24
Prospectus supplement for primary offering
5:08pm
424B5
d8nlumcz6 zq8pkd8
13 Feb 24
Prospectus supplement for primary offering
4:46pm
8-K
EX-99.2
g375q 669auzsox5h
12 Feb 24
Results of Operations and Financial Condition
7:03am
8-K
EX-99.2
m6357oo49krcms
14 Nov 23
Larimar Therapeutics Reports Third Quarter 2023 Operating and Financial Results
12:00am
8-K
EX-99.1
q7gfaejq1l
14 Aug 23
Other Events
8:00am
8-K
EX-99.1
lq42jj
1 Jun 23
June 2023 Larimar Therapeutics Corporate Presentation
4:06pm
8-K
EX-99.2
dlt1y0xc
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am